nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—Ethinyl Estradiol—osteoporosis	0.252	1	CrCtD
Norethindrone—polycystic ovary syndrome—Ethinyl Estradiol—osteoporosis	0.21	1	CpDpCtD
Norethindrone—SHBG—osteoporosis	0.125	1	CbGaD
Norethindrone—SHBG—Estropipate—osteoporosis	0.0445	0.292	CbGbCtD
Norethindrone—SHBG—Ethinyl Estradiol—osteoporosis	0.0287	0.188	CbGbCtD
Norethindrone—SHBG—Estradiol—osteoporosis	0.0185	0.121	CbGbCtD
Norethindrone—Formestane—Estropipate—osteoporosis	0.0147	0.0739	CrCrCtD
Norethindrone—Quinestrol—Estropipate—osteoporosis	0.0139	0.0702	CrCrCtD
Norethindrone—Mestranol—Estropipate—osteoporosis	0.0139	0.0702	CrCrCtD
Norethindrone—Ethinyl Estradiol—Estropipate—osteoporosis	0.0133	0.0669	CrCrCtD
Norethindrone—Desogestrel—Ethinyl Estradiol—osteoporosis	0.012	0.0603	CrCrCtD
Norethindrone—Formestane—Conjugated Estrogens—osteoporosis	0.0111	0.056	CrCrCtD
Norethindrone—Quinestrol—Conjugated Estrogens—osteoporosis	0.0106	0.0532	CrCrCtD
Norethindrone—Mestranol—Conjugated Estrogens—osteoporosis	0.0106	0.0532	CrCrCtD
Norethindrone—ALB—Estropipate—osteoporosis	0.0105	0.0691	CbGbCtD
Norethindrone—Ethinyl Estradiol—Conjugated Estrogens—osteoporosis	0.0101	0.0507	CrCrCtD
Norethindrone—Etonogestrel—Ethinyl Estradiol—osteoporosis	0.00988	0.0497	CrCrCtD
Norethindrone—Norelgestromin—Ethinyl Estradiol—osteoporosis	0.00935	0.0471	CrCrCtD
Norethindrone—Mestranol—Estradiol—osteoporosis	0.0091	0.0458	CrCrCtD
Norethindrone—Quinestrol—Estradiol—osteoporosis	0.0091	0.0458	CrCrCtD
Norethindrone—Quinestrol—Ethinyl Estradiol—osteoporosis	0.00888	0.0447	CrCrCtD
Norethindrone—Mestranol—Ethinyl Estradiol—osteoporosis	0.00888	0.0447	CrCrCtD
Norethindrone—Ethinyl Estradiol—Estradiol—osteoporosis	0.00867	0.0436	CrCrCtD
Norethindrone—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00774	0.039	CrCrCtD
Norethindrone—Danazol—Ethinyl Estradiol—osteoporosis	0.00714	0.036	CrCrCtD
Norethindrone—Methyltestosterone—Ethinyl Estradiol—osteoporosis	0.0051	0.0257	CrCrCtD
Norethindrone—CYP3A7—Estradiol—osteoporosis	0.00469	0.0308	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.00469	0.0308	CbGbCtD
Norethindrone—Testosterone—Estradiol—osteoporosis	0.00465	0.0234	CrCrCtD
Norethindrone—ALB—Estradiol—osteoporosis	0.00437	0.0287	CbGbCtD
Norethindrone—ABCB1—Ethinyl Estradiol—osteoporosis	0.00355	0.0233	CbGbCtD
Norethindrone—CYP2C19—Cholecalciferol—osteoporosis	0.00352	0.0231	CbGbCtD
Norethindrone—CYP3A5—Estradiol—osteoporosis	0.00352	0.0231	CbGbCtD
Norethindrone—CYP3A4—Estropipate—osteoporosis	0.0033	0.0217	CbGbCtD
Norethindrone—CYP3A4—Calcitriol—osteoporosis	0.0033	0.0217	CbGbCtD
Norethindrone—CYP2C19—Estradiol—osteoporosis	0.00284	0.0186	CbGbCtD
Norethindrone—CYP3A4—Ergocalciferol—osteoporosis	0.00264	0.0173	CbGbCtD
Norethindrone—ABCB1—Conjugated Estrogens—osteoporosis	0.00261	0.0171	CbGbCtD
Norethindrone—ABCB1—Estradiol—osteoporosis	0.00229	0.015	CbGbCtD
Norethindrone—CYP3A4—Raloxifene—osteoporosis	0.0022	0.0145	CbGbCtD
Norethindrone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00213	0.014	CbGbCtD
Norethindrone—CYP3A4—Cholecalciferol—osteoporosis	0.0017	0.0112	CbGbCtD
Norethindrone—CYP3A4—Conjugated Estrogens—osteoporosis	0.00156	0.0102	CbGbCtD
Norethindrone—CYP3A4—Estradiol—osteoporosis	0.00137	0.009	CbGbCtD
Norethindrone—Desogestrel—SHBG—osteoporosis	0.000109	0.0665	CrCbGaD
Norethindrone—Quinestrol—ESR1—osteoporosis	9.88e-05	0.06	CrCbGaD
Norethindrone—Nandrolone phenpropionate—CYP19A1—osteoporosis	9.13e-05	0.0554	CrCbGaD
Norethindrone—Etonogestrel—SHBG—osteoporosis	8.86e-05	0.0538	CrCbGaD
Norethindrone—Ethynodiol—ESR1—osteoporosis	8.13e-05	0.0494	CrCbGaD
Norethindrone—Allylestrenol—ESR1—osteoporosis	7.68e-05	0.0466	CrCbGaD
Norethindrone—Mestranol—ESR1—osteoporosis	7.48e-05	0.0455	CrCbGaD
Norethindrone—Desogestrel—ESR1—osteoporosis	7.39e-05	0.0449	CrCbGaD
Norethindrone—Norgestimate—ESR1—osteoporosis	6.92e-05	0.042	CrCbGaD
Norethindrone—Nandrolone decanoate—CYP19A1—osteoporosis	6.92e-05	0.042	CrCbGaD
Norethindrone—Levonorgestrel—SHBG—osteoporosis	6.27e-05	0.0381	CrCbGaD
Norethindrone—Etonogestrel—ESR1—osteoporosis	5.98e-05	0.0363	CrCbGaD
Norethindrone—Fluoxymesterone—SHBG—osteoporosis	5.97e-05	0.0363	CrCbGaD
Norethindrone—Ethinyl Estradiol—ESR2—osteoporosis	5.79e-05	0.0352	CrCbGaD
Norethindrone—Danazol—SHBG—osteoporosis	5.71e-05	0.0347	CrCbGaD
Norethindrone—Immune system disorder—Risedronate—osteoporosis	5.38e-05	0.001	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	5.37e-05	0.001	CcSEcCtD
Norethindrone—Oedema—Estropipate—osteoporosis	5.36e-05	0.000999	CcSEcCtD
Norethindrone—Anaphylactic shock—Estropipate—osteoporosis	5.36e-05	0.000999	CcSEcCtD
Norethindrone—Mental disorder—Ethinyl Estradiol—osteoporosis	5.35e-05	0.000999	CcSEcCtD
Norethindrone—Convulsion—Calcitriol—osteoporosis	5.34e-05	0.000996	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	5.32e-05	0.000993	CcSEcCtD
Norethindrone—Ethinyl Estradiol—SHBG—osteoporosis	5.28e-05	0.0321	CrCbGaD
Norethindrone—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	5.25e-05	0.000979	CcSEcCtD
Norethindrone—Mental disorder—Risedronate—osteoporosis	5.22e-05	0.000974	CcSEcCtD
Norethindrone—Breast disorder—Estradiol—osteoporosis	5.21e-05	0.000972	CcSEcCtD
Norethindrone—Skin disorder—Estropipate—osteoporosis	5.2e-05	0.000971	CcSEcCtD
Norethindrone—Anaphylactic shock—Ibandronate—osteoporosis	5.14e-05	0.000958	CcSEcCtD
Norethindrone—Immune system disorder—Pamidronate—osteoporosis	5.12e-05	0.000954	CcSEcCtD
Norethindrone—Flatulence—Risedronate—osteoporosis	5.11e-05	0.000953	CcSEcCtD
Norethindrone—Connective tissue disorder—Zoledronate—osteoporosis	5.08e-05	0.000948	CcSEcCtD
Norethindrone—Gastrointestinal pain—Etidronic acid—osteoporosis	5.06e-05	0.000944	CcSEcCtD
Norethindrone—Skin disorder—Raloxifene—osteoporosis	5.04e-05	0.00094	CcSEcCtD
Norethindrone—Anaphylactic shock—Calcitriol—osteoporosis	5.03e-05	0.000938	CcSEcCtD
Norethindrone—Abdominal distension—Estradiol—osteoporosis	5.01e-05	0.000935	CcSEcCtD
Norethindrone—Alopecia—Pamidronate—osteoporosis	5e-05	0.000934	CcSEcCtD
Norethindrone—Skin disorder—Ibandronate—osteoporosis	4.99e-05	0.000931	CcSEcCtD
Norethindrone—Nausea—Ergocalciferol—osteoporosis	4.95e-05	0.000923	CcSEcCtD
Norethindrone—Urticaria—Etidronic acid—osteoporosis	4.92e-05	0.000918	CcSEcCtD
Norethindrone—Abdominal pain—Etidronic acid—osteoporosis	4.89e-05	0.000913	CcSEcCtD
Norethindrone—Skin disorder—Calcitriol—osteoporosis	4.88e-05	0.000911	CcSEcCtD
Norethindrone—Insomnia—Estropipate—osteoporosis	4.84e-05	0.000904	CcSEcCtD
Norethindrone—Tension—Pamidronate—osteoporosis	4.84e-05	0.000903	CcSEcCtD
Norethindrone—Methyltestosterone—SHBG—osteoporosis	4.82e-05	0.0293	CrCbGaD
Norethindrone—Nervousness—Pamidronate—osteoporosis	4.79e-05	0.000893	CcSEcCtD
Norethindrone—Somnolence—Estropipate—osteoporosis	4.76e-05	0.000888	CcSEcCtD
Norethindrone—Dyspepsia—Estropipate—osteoporosis	4.71e-05	0.00088	CcSEcCtD
Norethindrone—Erythema multiforme—Conjugated Estrogens—osteoporosis	4.71e-05	0.000879	CcSEcCtD
Norethindrone—Insomnia—Raloxifene—osteoporosis	4.69e-05	0.000875	CcSEcCtD
Norethindrone—Immune system disorder—Zoledronate—osteoporosis	4.67e-05	0.000872	CcSEcCtD
Norethindrone—Insomnia—Ibandronate—osteoporosis	4.65e-05	0.000867	CcSEcCtD
Norethindrone—Dyspepsia—Alendronate—osteoporosis	4.64e-05	0.000866	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Estropipate—osteoporosis	4.62e-05	0.000863	CcSEcCtD
Norethindrone—Fatigue—Estropipate—osteoporosis	4.62e-05	0.000861	CcSEcCtD
Norethindrone—Levonorgestrel—CYP19A1—osteoporosis	4.6e-05	0.0279	CrCbGaD
Norethindrone—Alopecia—Zoledronate—osteoporosis	4.57e-05	0.000853	CcSEcCtD
Norethindrone—Dyspepsia—Raloxifene—osteoporosis	4.57e-05	0.000852	CcSEcCtD
Norethindrone—Hypersensitivity—Etidronic acid—osteoporosis	4.56e-05	0.000851	CcSEcCtD
Norethindrone—Insomnia—Calcitriol—osteoporosis	4.55e-05	0.000848	CcSEcCtD
Norethindrone—Photosensitivity reaction—Estradiol—osteoporosis	4.55e-05	0.000848	CcSEcCtD
Norethindrone—Weight increased—Estradiol—osteoporosis	4.53e-05	0.000846	CcSEcCtD
Norethindrone—Mental disorder—Zoledronate—osteoporosis	4.53e-05	0.000846	CcSEcCtD
Norethindrone—Dyspepsia—Ibandronate—osteoporosis	4.52e-05	0.000843	CcSEcCtD
Norethindrone—Immune system disorder—Conjugated Estrogens—osteoporosis	4.5e-05	0.000839	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	4.5e-05	0.000839	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Raloxifene—osteoporosis	4.48e-05	0.000836	CcSEcCtD
Norethindrone—Somnolence—Calcitriol—osteoporosis	4.47e-05	0.000834	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Ibandronate—osteoporosis	4.43e-05	0.000827	CcSEcCtD
Norethindrone—Depression—Estradiol—osteoporosis	4.43e-05	0.000826	CcSEcCtD
Norethindrone—Fatigue—Ibandronate—osteoporosis	4.43e-05	0.000826	CcSEcCtD
Norethindrone—Alopecia—Conjugated Estrogens—osteoporosis	4.4e-05	0.000821	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	4.38e-05	0.000818	CcSEcCtD
Norethindrone—Pruritus—Etidronic acid—osteoporosis	4.38e-05	0.000817	CcSEcCtD
Norethindrone—Gastrointestinal pain—Estropipate—osteoporosis	4.38e-05	0.000817	CcSEcCtD
Norethindrone—Acute coronary syndrome—Estradiol—osteoporosis	4.38e-05	0.000817	CcSEcCtD
Norethindrone—Mental disorder—Conjugated Estrogens—osteoporosis	4.36e-05	0.000814	CcSEcCtD
Norethindrone—Myocardial infarction—Estradiol—osteoporosis	4.35e-05	0.000812	CcSEcCtD
Norethindrone—Oedema—Ethinyl Estradiol—osteoporosis	4.34e-05	0.00081	CcSEcCtD
Norethindrone—Gastrointestinal pain—Alendronate—osteoporosis	4.31e-05	0.000805	CcSEcCtD
Norethindrone—Flatulence—Conjugated Estrogens—osteoporosis	4.27e-05	0.000797	CcSEcCtD
Norethindrone—Convulsion—Pamidronate—osteoporosis	4.27e-05	0.000797	CcSEcCtD
Norethindrone—Tension—Conjugated Estrogens—osteoporosis	4.25e-05	0.000794	CcSEcCtD
Norethindrone—Urticaria—Estropipate—osteoporosis	4.25e-05	0.000794	CcSEcCtD
Norethindrone—Gastrointestinal pain—Raloxifene—osteoporosis	4.24e-05	0.000791	CcSEcCtD
Norethindrone—Abdominal pain—Estropipate—osteoporosis	4.23e-05	0.00079	CcSEcCtD
Norethindrone—Levonorgestrel—ESR1—osteoporosis	4.23e-05	0.0257	CrCbGaD
Norethindrone—Skin disorder—Ethinyl Estradiol—osteoporosis	4.22e-05	0.000787	CcSEcCtD
Norethindrone—Nervousness—Conjugated Estrogens—osteoporosis	4.21e-05	0.000786	CcSEcCtD
Norethindrone—Hepatobiliary disease—Estradiol—osteoporosis	4.2e-05	0.000784	CcSEcCtD
Norethindrone—Gastrointestinal pain—Ibandronate—osteoporosis	4.2e-05	0.000784	CcSEcCtD
Norethindrone—Urticaria—Alendronate—osteoporosis	4.19e-05	0.000782	CcSEcCtD
Norethindrone—Danazol—CYP19A1—osteoporosis	4.19e-05	0.0254	CrCbGaD
Norethindrone—Abdominal pain—Alendronate—osteoporosis	4.17e-05	0.000778	CcSEcCtD
Norethindrone—Skin disorder—Risedronate—osteoporosis	4.11e-05	0.000767	CcSEcCtD
Norethindrone—Gastrointestinal pain—Calcitriol—osteoporosis	4.11e-05	0.000767	CcSEcCtD
Norethindrone—Abdominal pain—Raloxifene—osteoporosis	4.1e-05	0.000765	CcSEcCtD
Norethindrone—Urticaria—Ibandronate—osteoporosis	4.08e-05	0.000761	CcSEcCtD
Norethindrone—Abdominal pain—Ibandronate—osteoporosis	4.06e-05	0.000757	CcSEcCtD
Norethindrone—Fluoxymesterone—ESR1—osteoporosis	4.03e-05	0.0245	CrCbGaD
Norethindrone—Anaphylactic shock—Pamidronate—osteoporosis	4.02e-05	0.000751	CcSEcCtD
Norethindrone—Oedema—Pamidronate—osteoporosis	4.02e-05	0.000751	CcSEcCtD
Norethindrone—Haemoglobin—Estradiol—osteoporosis	4.01e-05	0.000748	CcSEcCtD
Norethindrone—Urticaria—Calcitriol—osteoporosis	3.99e-05	0.000745	CcSEcCtD
Norethindrone—Haemorrhage—Estradiol—osteoporosis	3.99e-05	0.000744	CcSEcCtD
Norethindrone—Hepatitis—Estradiol—osteoporosis	3.99e-05	0.000744	CcSEcCtD
Norethindrone—Abdominal pain—Calcitriol—osteoporosis	3.97e-05	0.000742	CcSEcCtD
Norethindrone—Hypersensitivity—Estropipate—osteoporosis	3.95e-05	0.000736	CcSEcCtD
Norethindrone—Vomiting—Etidronic acid—osteoporosis	3.94e-05	0.000734	CcSEcCtD
Norethindrone—Connective tissue disorder—Estradiol—osteoporosis	3.92e-05	0.000731	CcSEcCtD
Norethindrone—Rash—Etidronic acid—osteoporosis	3.9e-05	0.000728	CcSEcCtD
Norethindrone—Convulsion—Zoledronate—osteoporosis	3.9e-05	0.000728	CcSEcCtD
Norethindrone—Dermatitis—Etidronic acid—osteoporosis	3.9e-05	0.000728	CcSEcCtD
Norethindrone—Hypersensitivity—Alendronate—osteoporosis	3.89e-05	0.000725	CcSEcCtD
Norethindrone—Headache—Etidronic acid—osteoporosis	3.88e-05	0.000724	CcSEcCtD
Norethindrone—Danazol—ESR1—osteoporosis	3.86e-05	0.0234	CrCbGaD
Norethindrone—Asthenia—Estropipate—osteoporosis	3.84e-05	0.000717	CcSEcCtD
Norethindrone—Insomnia—Risedronate—osteoporosis	3.83e-05	0.000714	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	3.81e-05	0.00071	CcSEcCtD
Norethindrone—Pruritus—Estropipate—osteoporosis	3.79e-05	0.000707	CcSEcCtD
Norethindrone—Asthenia—Alendronate—osteoporosis	3.78e-05	0.000706	CcSEcCtD
Norethindrone—Hypersensitivity—Ibandronate—osteoporosis	3.78e-05	0.000706	CcSEcCtD
Norethindrone—Erythema multiforme—Estradiol—osteoporosis	3.77e-05	0.000703	CcSEcCtD
Norethindrone—Convulsion—Conjugated Estrogens—osteoporosis	3.76e-05	0.000701	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	3.75e-05	0.000699	CcSEcCtD
Norethindrone—Fatigue—Ethinyl Estradiol—osteoporosis	3.74e-05	0.000698	CcSEcCtD
Norethindrone—Pruritus—Alendronate—osteoporosis	3.73e-05	0.000696	CcSEcCtD
Norethindrone—Dyspepsia—Risedronate—osteoporosis	3.73e-05	0.000695	CcSEcCtD
Norethindrone—Hypersensitivity—Calcitriol—osteoporosis	3.7e-05	0.000691	CcSEcCtD
Norethindrone—Asthenia—Ibandronate—osteoporosis	3.68e-05	0.000687	CcSEcCtD
Norethindrone—Nausea—Etidronic acid—osteoporosis	3.68e-05	0.000686	CcSEcCtD
Norethindrone—Anaphylactic shock—Zoledronate—osteoporosis	3.68e-05	0.000686	CcSEcCtD
Norethindrone—Oedema—Zoledronate—osteoporosis	3.68e-05	0.000686	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	3.67e-05	0.000684	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Risedronate—osteoporosis	3.65e-05	0.000682	CcSEcCtD
Norethindrone—Fatigue—Risedronate—osteoporosis	3.65e-05	0.000681	CcSEcCtD
Norethindrone—Insomnia—Pamidronate—osteoporosis	3.64e-05	0.000679	CcSEcCtD
Norethindrone—Pruritus—Ibandronate—osteoporosis	3.63e-05	0.000678	CcSEcCtD
Norethindrone—Hydrocortisone—SHBG—osteoporosis	3.63e-05	0.0221	CrCbGaD
Norethindrone—Asthenia—Calcitriol—osteoporosis	3.61e-05	0.000673	CcSEcCtD
Norethindrone—Immune system disorder—Estradiol—osteoporosis	3.6e-05	0.000672	CcSEcCtD
Norethindrone—Somnolence—Pamidronate—osteoporosis	3.58e-05	0.000667	CcSEcCtD
Norethindrone—Skin disorder—Zoledronate—osteoporosis	3.57e-05	0.000666	CcSEcCtD
Norethindrone—Ethinyl Estradiol—ESR1—osteoporosis	3.57e-05	0.0217	CrCbGaD
Norethindrone—Pruritus—Calcitriol—osteoporosis	3.56e-05	0.000664	CcSEcCtD
Norethindrone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	3.55e-05	0.000662	CcSEcCtD
Norethindrone—Dyspepsia—Pamidronate—osteoporosis	3.54e-05	0.000661	CcSEcCtD
Norethindrone—Dizziness—Estropipate—osteoporosis	3.54e-05	0.000661	CcSEcCtD
Norethindrone—Methyltestosterone—CYP19A1—osteoporosis	3.54e-05	0.0215	CrCbGaD
Norethindrone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	3.54e-05	0.00066	CcSEcCtD
Norethindrone—Oedema—Conjugated Estrogens—osteoporosis	3.54e-05	0.00066	CcSEcCtD
Norethindrone—Alopecia—Estradiol—osteoporosis	3.52e-05	0.000657	CcSEcCtD
Norethindrone—Mental disorder—Estradiol—osteoporosis	3.49e-05	0.000652	CcSEcCtD
Norethindrone—Dizziness—Alendronate—osteoporosis	3.49e-05	0.000651	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Pamidronate—osteoporosis	3.47e-05	0.000648	CcSEcCtD
Norethindrone—Fatigue—Pamidronate—osteoporosis	3.47e-05	0.000647	CcSEcCtD
Norethindrone—Gastrointestinal pain—Risedronate—osteoporosis	3.46e-05	0.000646	CcSEcCtD
Norethindrone—Urticaria—Ethinyl Estradiol—osteoporosis	3.45e-05	0.000643	CcSEcCtD
Norethindrone—Skin disorder—Conjugated Estrogens—osteoporosis	3.44e-05	0.000641	CcSEcCtD
Norethindrone—Abdominal pain—Ethinyl Estradiol—osteoporosis	3.43e-05	0.00064	CcSEcCtD
Norethindrone—Dizziness—Raloxifene—osteoporosis	3.43e-05	0.00064	CcSEcCtD
Norethindrone—Flatulence—Estradiol—osteoporosis	3.42e-05	0.000638	CcSEcCtD
Norethindrone—Tension—Estradiol—osteoporosis	3.41e-05	0.000635	CcSEcCtD
Norethindrone—Vomiting—Estropipate—osteoporosis	3.41e-05	0.000635	CcSEcCtD
Norethindrone—Dizziness—Ibandronate—osteoporosis	3.4e-05	0.000634	CcSEcCtD
Norethindrone—Rash—Estropipate—osteoporosis	3.38e-05	0.00063	CcSEcCtD
Norethindrone—Dermatitis—Estropipate—osteoporosis	3.37e-05	0.000629	CcSEcCtD
Norethindrone—Nervousness—Estradiol—osteoporosis	3.37e-05	0.000629	CcSEcCtD
Norethindrone—Urticaria—Risedronate—osteoporosis	3.36e-05	0.000627	CcSEcCtD
Norethindrone—Headache—Estropipate—osteoporosis	3.36e-05	0.000626	CcSEcCtD
Norethindrone—Vomiting—Alendronate—osteoporosis	3.35e-05	0.000626	CcSEcCtD
Norethindrone—Abdominal pain—Risedronate—osteoporosis	3.35e-05	0.000624	CcSEcCtD
Norethindrone—Rash—Alendronate—osteoporosis	3.33e-05	0.000621	CcSEcCtD
Norethindrone—Insomnia—Zoledronate—osteoporosis	3.32e-05	0.00062	CcSEcCtD
Norethindrone—Dermatitis—Alendronate—osteoporosis	3.32e-05	0.00062	CcSEcCtD
Norethindrone—Headache—Alendronate—osteoporosis	3.3e-05	0.000617	CcSEcCtD
Norethindrone—Vomiting—Raloxifene—osteoporosis	3.3e-05	0.000615	CcSEcCtD
Norethindrone—Gastrointestinal pain—Pamidronate—osteoporosis	3.29e-05	0.000614	CcSEcCtD
Norethindrone—Rash—Raloxifene—osteoporosis	3.27e-05	0.00061	CcSEcCtD
Norethindrone—Dermatitis—Raloxifene—osteoporosis	3.27e-05	0.00061	CcSEcCtD
Norethindrone—Somnolence—Zoledronate—osteoporosis	3.27e-05	0.00061	CcSEcCtD
Norethindrone—Vomiting—Ibandronate—osteoporosis	3.27e-05	0.000609	CcSEcCtD
Norethindrone—Headache—Raloxifene—osteoporosis	3.25e-05	0.000606	CcSEcCtD
Norethindrone—Rash—Ibandronate—osteoporosis	3.24e-05	0.000604	CcSEcCtD
Norethindrone—Dermatitis—Ibandronate—osteoporosis	3.24e-05	0.000604	CcSEcCtD
Norethindrone—Dyspepsia—Zoledronate—osteoporosis	3.24e-05	0.000604	CcSEcCtD
Norethindrone—Headache—Ibandronate—osteoporosis	3.22e-05	0.0006	CcSEcCtD
Norethindrone—Insomnia—Conjugated Estrogens—osteoporosis	3.2e-05	0.000597	CcSEcCtD
Norethindrone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	3.2e-05	0.000597	CcSEcCtD
Norethindrone—Vomiting—Calcitriol—osteoporosis	3.2e-05	0.000596	CcSEcCtD
Norethindrone—Nausea—Estropipate—osteoporosis	3.18e-05	0.000594	CcSEcCtD
Norethindrone—Abdominal pain—Pamidronate—osteoporosis	3.18e-05	0.000593	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Zoledronate—osteoporosis	3.17e-05	0.000592	CcSEcCtD
Norethindrone—Rash—Calcitriol—osteoporosis	3.17e-05	0.000591	CcSEcCtD
Norethindrone—Fatigue—Zoledronate—osteoporosis	3.17e-05	0.000591	CcSEcCtD
Norethindrone—Dermatitis—Calcitriol—osteoporosis	3.17e-05	0.000591	CcSEcCtD
Norethindrone—Headache—Calcitriol—osteoporosis	3.15e-05	0.000588	CcSEcCtD
Norethindrone—Somnolence—Conjugated Estrogens—osteoporosis	3.15e-05	0.000587	CcSEcCtD
Norethindrone—Nausea—Alendronate—osteoporosis	3.13e-05	0.000585	CcSEcCtD
Norethindrone—Hypersensitivity—Risedronate—osteoporosis	3.12e-05	0.000582	CcSEcCtD
Norethindrone—Dyspepsia—Conjugated Estrogens—osteoporosis	3.11e-05	0.000581	CcSEcCtD
Norethindrone—Asthenia—Ethinyl Estradiol—osteoporosis	3.11e-05	0.000581	CcSEcCtD
Norethindrone—Nausea—Raloxifene—osteoporosis	3.08e-05	0.000575	CcSEcCtD
Norethindrone—Pruritus—Ethinyl Estradiol—osteoporosis	3.07e-05	0.000573	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	3.06e-05	0.00057	CcSEcCtD
Norethindrone—Fatigue—Conjugated Estrogens—osteoporosis	3.05e-05	0.000569	CcSEcCtD
Norethindrone—Nausea—Ibandronate—osteoporosis	3.05e-05	0.000569	CcSEcCtD
Norethindrone—Asthenia—Risedronate—osteoporosis	3.04e-05	0.000567	CcSEcCtD
Norethindrone—Gastrointestinal pain—Zoledronate—osteoporosis	3.01e-05	0.000561	CcSEcCtD
Norethindrone—Pruritus—Risedronate—osteoporosis	2.99e-05	0.000559	CcSEcCtD
Norethindrone—Nausea—Calcitriol—osteoporosis	2.99e-05	0.000557	CcSEcCtD
Norethindrone—Hypersensitivity—Pamidronate—osteoporosis	2.96e-05	0.000553	CcSEcCtD
Norethindrone—Progesterone—SHBG—osteoporosis	2.96e-05	0.018	CrCbGaD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	2.93e-05	0.000547	CcSEcCtD
Norethindrone—Urticaria—Zoledronate—osteoporosis	2.92e-05	0.000545	CcSEcCtD
Norethindrone—Abdominal pain—Zoledronate—osteoporosis	2.91e-05	0.000542	CcSEcCtD
Norethindrone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	2.89e-05	0.00054	CcSEcCtD
Norethindrone—Asthenia—Pamidronate—osteoporosis	2.89e-05	0.000539	CcSEcCtD
Norethindrone—Dizziness—Ethinyl Estradiol—osteoporosis	2.87e-05	0.000536	CcSEcCtD
Norethindrone—Pruritus—Pamidronate—osteoporosis	2.85e-05	0.000531	CcSEcCtD
Norethindrone—Anaphylactic shock—Estradiol—osteoporosis	2.83e-05	0.000528	CcSEcCtD
Norethindrone—Oedema—Estradiol—osteoporosis	2.83e-05	0.000528	CcSEcCtD
Norethindrone—Urticaria—Conjugated Estrogens—osteoporosis	2.81e-05	0.000525	CcSEcCtD
Norethindrone—Dizziness—Risedronate—osteoporosis	2.8e-05	0.000522	CcSEcCtD
Norethindrone—Testosterone—SHBG—osteoporosis	2.8e-05	0.017	CrCbGaD
Norethindrone—Abdominal pain—Conjugated Estrogens—osteoporosis	2.8e-05	0.000522	CcSEcCtD
Norethindrone—Vomiting—Ethinyl Estradiol—osteoporosis	2.76e-05	0.000515	CcSEcCtD
Norethindrone—Skin disorder—Estradiol—osteoporosis	2.75e-05	0.000513	CcSEcCtD
Norethindrone—Rash—Ethinyl Estradiol—osteoporosis	2.74e-05	0.000511	CcSEcCtD
Norethindrone—Dermatitis—Ethinyl Estradiol—osteoporosis	2.73e-05	0.00051	CcSEcCtD
Norethindrone—Headache—Ethinyl Estradiol—osteoporosis	2.72e-05	0.000507	CcSEcCtD
Norethindrone—Hypersensitivity—Zoledronate—osteoporosis	2.71e-05	0.000505	CcSEcCtD
Norethindrone—Vomiting—Risedronate—osteoporosis	2.69e-05	0.000502	CcSEcCtD
Norethindrone—Rash—Risedronate—osteoporosis	2.67e-05	0.000498	CcSEcCtD
Norethindrone—Dermatitis—Risedronate—osteoporosis	2.67e-05	0.000497	CcSEcCtD
Norethindrone—Dizziness—Pamidronate—osteoporosis	2.66e-05	0.000496	CcSEcCtD
Norethindrone—Headache—Risedronate—osteoporosis	2.65e-05	0.000495	CcSEcCtD
Norethindrone—Asthenia—Zoledronate—osteoporosis	2.64e-05	0.000492	CcSEcCtD
Norethindrone—Hypersensitivity—Conjugated Estrogens—osteoporosis	2.61e-05	0.000486	CcSEcCtD
Norethindrone—Pruritus—Zoledronate—osteoporosis	2.6e-05	0.000485	CcSEcCtD
Norethindrone—Nausea—Ethinyl Estradiol—osteoporosis	2.58e-05	0.000481	CcSEcCtD
Norethindrone—Insomnia—Estradiol—osteoporosis	2.56e-05	0.000478	CcSEcCtD
Norethindrone—Vomiting—Pamidronate—osteoporosis	2.56e-05	0.000477	CcSEcCtD
Norethindrone—Asthenia—Conjugated Estrogens—osteoporosis	2.54e-05	0.000474	CcSEcCtD
Norethindrone—Rash—Pamidronate—osteoporosis	2.54e-05	0.000473	CcSEcCtD
Norethindrone—Dermatitis—Pamidronate—osteoporosis	2.53e-05	0.000473	CcSEcCtD
Norethindrone—Headache—Pamidronate—osteoporosis	2.52e-05	0.00047	CcSEcCtD
Norethindrone—Somnolence—Estradiol—osteoporosis	2.52e-05	0.00047	CcSEcCtD
Norethindrone—Nausea—Risedronate—osteoporosis	2.51e-05	0.000469	CcSEcCtD
Norethindrone—Pruritus—Conjugated Estrogens—osteoporosis	2.5e-05	0.000467	CcSEcCtD
Norethindrone—Dyspepsia—Estradiol—osteoporosis	2.49e-05	0.000465	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Estradiol—osteoporosis	2.45e-05	0.000456	CcSEcCtD
Norethindrone—Fatigue—Estradiol—osteoporosis	2.44e-05	0.000456	CcSEcCtD
Norethindrone—Dizziness—Zoledronate—osteoporosis	2.43e-05	0.000453	CcSEcCtD
Norethindrone—Nausea—Pamidronate—osteoporosis	2.39e-05	0.000446	CcSEcCtD
Norethindrone—Dizziness—Conjugated Estrogens—osteoporosis	2.34e-05	0.000437	CcSEcCtD
Norethindrone—Vomiting—Zoledronate—osteoporosis	2.34e-05	0.000436	CcSEcCtD
Norethindrone—Rash—Zoledronate—osteoporosis	2.32e-05	0.000432	CcSEcCtD
Norethindrone—Gastrointestinal pain—Estradiol—osteoporosis	2.32e-05	0.000432	CcSEcCtD
Norethindrone—Dermatitis—Zoledronate—osteoporosis	2.32e-05	0.000432	CcSEcCtD
Norethindrone—Headache—Zoledronate—osteoporosis	2.3e-05	0.00043	CcSEcCtD
Norethindrone—Vomiting—Conjugated Estrogens—osteoporosis	2.25e-05	0.00042	CcSEcCtD
Norethindrone—Urticaria—Estradiol—osteoporosis	2.25e-05	0.00042	CcSEcCtD
Norethindrone—Abdominal pain—Estradiol—osteoporosis	2.24e-05	0.000418	CcSEcCtD
Norethindrone—Rash—Conjugated Estrogens—osteoporosis	2.23e-05	0.000416	CcSEcCtD
Norethindrone—Dermatitis—Conjugated Estrogens—osteoporosis	2.23e-05	0.000416	CcSEcCtD
Norethindrone—Headache—Conjugated Estrogens—osteoporosis	2.22e-05	0.000414	CcSEcCtD
Norethindrone—Nausea—Zoledronate—osteoporosis	2.18e-05	0.000407	CcSEcCtD
Norethindrone—Nausea—Conjugated Estrogens—osteoporosis	2.1e-05	0.000392	CcSEcCtD
Norethindrone—Hypersensitivity—Estradiol—osteoporosis	2.09e-05	0.000389	CcSEcCtD
Norethindrone—Testosterone—CYP19A1—osteoporosis	2.05e-05	0.0125	CrCbGaD
Norethindrone—Asthenia—Estradiol—osteoporosis	2.03e-05	0.000379	CcSEcCtD
Norethindrone—Pruritus—Estradiol—osteoporosis	2e-05	0.000374	CcSEcCtD
Norethindrone—Progesterone—ESR1—osteoporosis	2e-05	0.0121	CrCbGaD
Norethindrone—Dizziness—Estradiol—osteoporosis	1.87e-05	0.000349	CcSEcCtD
Norethindrone—Vomiting—Estradiol—osteoporosis	1.8e-05	0.000336	CcSEcCtD
Norethindrone—Rash—Estradiol—osteoporosis	1.79e-05	0.000333	CcSEcCtD
Norethindrone—Dermatitis—Estradiol—osteoporosis	1.78e-05	0.000333	CcSEcCtD
Norethindrone—Headache—Estradiol—osteoporosis	1.77e-05	0.000331	CcSEcCtD
Norethindrone—Nausea—Estradiol—osteoporosis	1.68e-05	0.000314	CcSEcCtD
Norethindrone—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	1.15e-05	0.00173	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	1.13e-05	0.0017	CbGpPWpGaD
Norethindrone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.11e-05	0.00168	CbGpPWpGaD
Norethindrone—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	1.11e-05	0.00168	CbGpPWpGaD
Norethindrone—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.11e-05	0.00168	CbGpPWpGaD
Norethindrone—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	1.11e-05	0.00168	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—MGLL—osteoporosis	1.1e-05	0.00166	CbGpPWpGaD
Norethindrone—CYP3A7—Biological oxidations—POMC—osteoporosis	1.06e-05	0.0016	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MGLL—osteoporosis	1.05e-05	0.00159	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—IL1B—osteoporosis	1.05e-05	0.00159	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.03e-05	0.00155	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—LRP5—osteoporosis	1.03e-05	0.00155	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PLEK—osteoporosis	1.01e-05	0.00152	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—ANXA2—osteoporosis	1.01e-05	0.00152	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1e-05	0.00151	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—FDPS—osteoporosis	9.98e-06	0.0015	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PKM—osteoporosis	9.98e-06	0.0015	CbGpPWpGaD
Norethindrone—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	9.84e-06	0.00148	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—LRP6—osteoporosis	9.84e-06	0.00148	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	9.73e-06	0.00147	CbGpPWpGaD
Norethindrone—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	9.71e-06	0.00146	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PGLS—osteoporosis	9.46e-06	0.00143	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GPD2—osteoporosis	9.46e-06	0.00143	CbGpPWpGaD
Norethindrone—PGR—Generic Transcription Pathway—ESR1—osteoporosis	9.44e-06	0.00142	CbGpPWpGaD
Norethindrone—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	9.38e-06	0.00141	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	9.24e-06	0.00139	CbGpPWpGaD
Norethindrone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	9.11e-06	0.00137	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	9e-06	0.00136	CbGpPWpGaD
Norethindrone—PGR—Signaling by ERBB4—IL6—osteoporosis	8.92e-06	0.00134	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	8.72e-06	0.00131	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TLN1—osteoporosis	8.68e-06	0.00131	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PNP—osteoporosis	8.66e-06	0.0013	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ATIC—osteoporosis	8.66e-06	0.0013	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—VCL—osteoporosis	8.56e-06	0.00129	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—PSMA2—osteoporosis	8.39e-06	0.00126	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—PSMA5—osteoporosis	8.39e-06	0.00126	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	8.36e-06	0.00126	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TLN1—osteoporosis	8.3e-06	0.00125	CbGpPWpGaD
Norethindrone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	8.26e-06	0.00125	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	8.02e-06	0.00121	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—IL1B—osteoporosis	7.98e-06	0.0012	CbGpPWpGaD
Norethindrone—CYP3A5—Biological oxidations—POMC—osteoporosis	7.65e-06	0.00115	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	7.64e-06	0.00115	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—TNF—osteoporosis	7.64e-06	0.00115	CbGpPWpGaD
Norethindrone—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	7.57e-06	0.00114	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—ESR2—osteoporosis	7.49e-06	0.00113	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—OXCT1—osteoporosis	7.36e-06	0.00111	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CA2—osteoporosis	7.36e-06	0.00111	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PKM—osteoporosis	7.22e-06	0.00109	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—FDPS—osteoporosis	7.22e-06	0.00109	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	7.2e-06	0.00108	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—MGLL—osteoporosis	7.17e-06	0.00108	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—P4HB—osteoporosis	7.16e-06	0.00108	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—RAP1A—osteoporosis	7.16e-06	0.00108	CbGpPWpGaD
Norethindrone—ALB—Platelet degranulation—TGFB1—osteoporosis	7.01e-06	0.00106	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PTH—osteoporosis	6.97e-06	0.00105	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—RAP1A—osteoporosis	6.85e-06	0.00103	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GPD2—osteoporosis	6.84e-06	0.00103	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PGLS—osteoporosis	6.84e-06	0.00103	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.82e-06	0.00103	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CNR2—osteoporosis	6.79e-06	0.00102	CbGpPWpGaD
Norethindrone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.7e-06	0.00101	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NFATC1—osteoporosis	6.68e-06	0.00101	CbGpPWpGaD
Norethindrone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	6.68e-06	0.00101	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—DKK1—osteoporosis	6.63e-06	0.000999	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—FGA—osteoporosis	6.49e-06	0.000978	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—WNT1—osteoporosis	6.38e-06	0.000962	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ATIC—osteoporosis	6.26e-06	0.000943	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PNP—osteoporosis	6.26e-06	0.000943	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PKM—osteoporosis	6.22e-06	0.000937	CbGpPWpGaD
Norethindrone—ALB—Metabolism—FDPS—osteoporosis	6.22e-06	0.000937	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—FGA—osteoporosis	6.21e-06	0.000936	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—TGFB1—osteoporosis	6.2e-06	0.000935	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—IL6—osteoporosis	6.16e-06	0.000929	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.12e-06	0.000922	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—IDH2—osteoporosis	6.1e-06	0.000919	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—TNF—osteoporosis	6.07e-06	0.000914	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—VDR—osteoporosis	5.95e-06	0.000897	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	5.92e-06	0.000892	CbGpPWpGaD
Norethindrone—CYP2C19—Biological oxidations—POMC—osteoporosis	5.92e-06	0.000892	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—FGB—osteoporosis	5.91e-06	0.00089	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	5.9e-06	0.000889	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GPD2—osteoporosis	5.89e-06	0.000888	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PGLS—osteoporosis	5.89e-06	0.000888	CbGpPWpGaD
Norethindrone—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	5.84e-06	0.00088	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—TNF—osteoporosis	5.79e-06	0.000873	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PTHLH—osteoporosis	5.77e-06	0.00087	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—BMP2—osteoporosis	5.77e-06	0.00087	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CYP27A1—osteoporosis	5.73e-06	0.000864	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—FGB—osteoporosis	5.65e-06	0.000851	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—FDPS—osteoporosis	5.58e-06	0.000841	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PKM—osteoporosis	5.58e-06	0.000841	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ACP5—osteoporosis	5.58e-06	0.000841	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PSMA5—osteoporosis	5.45e-06	0.000822	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PSMA2—osteoporosis	5.45e-06	0.000822	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—FDPS—osteoporosis	5.45e-06	0.000821	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PKM—osteoporosis	5.45e-06	0.000821	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PNP—osteoporosis	5.39e-06	0.000812	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ATIC—osteoporosis	5.39e-06	0.000812	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CA2—osteoporosis	5.32e-06	0.000802	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—OXCT1—osteoporosis	5.32e-06	0.000802	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PGLS—osteoporosis	5.29e-06	0.000797	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GPD2—osteoporosis	5.29e-06	0.000797	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	5.19e-06	0.000782	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—TPI1—osteoporosis	5.19e-06	0.000782	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—MGLL—osteoporosis	5.18e-06	0.000782	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PGLS—osteoporosis	5.16e-06	0.000778	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GPD2—osteoporosis	5.16e-06	0.000778	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	5.11e-06	0.00077	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CALCA—osteoporosis	5.08e-06	0.000766	CbGpPWpGaD
Norethindrone—PGR—Generic Transcription Pathway—MYC—osteoporosis	4.91e-06	0.00074	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—IL6—osteoporosis	4.89e-06	0.000738	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—P4HB—osteoporosis	4.88e-06	0.000735	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ATIC—osteoporosis	4.84e-06	0.000729	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PNP—osteoporosis	4.84e-06	0.000729	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GAPDH—osteoporosis	4.79e-06	0.000721	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ATIC—osteoporosis	4.72e-06	0.000712	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PNP—osteoporosis	4.72e-06	0.000712	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—RAP1A—osteoporosis	4.66e-06	0.000703	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—KL—osteoporosis	4.61e-06	0.000696	CbGpPWpGaD
Norethindrone—ALB—Metabolism—OXCT1—osteoporosis	4.58e-06	0.000691	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CA2—osteoporosis	4.58e-06	0.000691	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—ESR1—osteoporosis	4.54e-06	0.000685	CbGpPWpGaD
Norethindrone—ALB—Metabolism—MGLL—osteoporosis	4.47e-06	0.000673	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—IDH2—osteoporosis	4.41e-06	0.000665	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.21e-06	0.000635	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYP27A1—osteoporosis	4.14e-06	0.000625	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—OXCT1—osteoporosis	4.11e-06	0.00062	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CA2—osteoporosis	4.11e-06	0.00062	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ACP5—osteoporosis	4.03e-06	0.000608	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CA2—osteoporosis	4.01e-06	0.000605	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—OXCT1—osteoporosis	4.01e-06	0.000605	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—MGLL—osteoporosis	4.01e-06	0.000604	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MGLL—osteoporosis	3.91e-06	0.00059	CbGpPWpGaD
Norethindrone—ALB—Metabolism—IDH2—osteoporosis	3.8e-06	0.000572	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.78e-06	0.00057	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ENO1—osteoporosis	3.77e-06	0.000568	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—TPI1—osteoporosis	3.75e-06	0.000565	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PSMA2—osteoporosis	3.71e-06	0.00056	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PSMA5—osteoporosis	3.71e-06	0.00056	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—ADCY5—osteoporosis	3.61e-06	0.000545	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP27A1—osteoporosis	3.57e-06	0.000538	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—POMC—osteoporosis	3.56e-06	0.000536	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—P4HB—osteoporosis	3.52e-06	0.000531	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—SPP1—osteoporosis	3.5e-06	0.000527	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ACP5—osteoporosis	3.47e-06	0.000523	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GAPDH—osteoporosis	3.46e-06	0.000521	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.43e-06	0.000517	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—IDH2—osteoporosis	3.41e-06	0.000514	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—RAP1A—osteoporosis	3.37e-06	0.000508	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PKM—osteoporosis	3.36e-06	0.000506	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—FDPS—osteoporosis	3.36e-06	0.000506	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—IDH2—osteoporosis	3.33e-06	0.000501	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.27e-06	0.000493	CbGpPWpGaD
Norethindrone—ALB—Metabolism—TPI1—osteoporosis	3.23e-06	0.000487	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP27A1—osteoporosis	3.2e-06	0.000483	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GPD2—osteoporosis	3.18e-06	0.000479	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PGLS—osteoporosis	3.18e-06	0.000479	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IRS2—osteoporosis	3.16e-06	0.000477	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP27A1—osteoporosis	3.13e-06	0.000471	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ACP5—osteoporosis	3.12e-06	0.00047	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	3.11e-06	0.000469	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—LEP—osteoporosis	3.1e-06	0.000467	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.08e-06	0.000464	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	3.07e-06	0.000463	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	3.06e-06	0.000462	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ACP5—osteoporosis	3.04e-06	0.000459	CbGpPWpGaD
Norethindrone—ALB—Metabolism—P4HB—osteoporosis	3.04e-06	0.000458	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CYP19A1—osteoporosis	3.01e-06	0.000454	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GAPDH—osteoporosis	2.98e-06	0.000449	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—ESR1—osteoporosis	2.95e-06	0.000445	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PNP—osteoporosis	2.91e-06	0.000438	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ATIC—osteoporosis	2.91e-06	0.000438	CbGpPWpGaD
Norethindrone—ALB—Metabolism—RAP1A—osteoporosis	2.9e-06	0.000437	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—TPI1—osteoporosis	2.9e-06	0.000437	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.87e-06	0.000432	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.86e-06	0.000431	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—TPI1—osteoporosis	2.83e-06	0.000426	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IRS1—osteoporosis	2.76e-06	0.000416	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—P4HB—osteoporosis	2.72e-06	0.000411	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ENO1—osteoporosis	2.72e-06	0.000411	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PSMA2—osteoporosis	2.68e-06	0.000405	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PSMA5—osteoporosis	2.68e-06	0.000405	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GAPDH—osteoporosis	2.67e-06	0.000403	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—IGF1—osteoporosis	2.67e-06	0.000403	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—P4HB—osteoporosis	2.66e-06	0.000401	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—POMC—osteoporosis	2.66e-06	0.000401	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GAPDH—osteoporosis	2.61e-06	0.000393	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—RAP1A—osteoporosis	2.6e-06	0.000393	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL6R—osteoporosis	2.59e-06	0.000391	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IGF1—osteoporosis	2.56e-06	0.000386	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—RAP1A—osteoporosis	2.54e-06	0.000383	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.53e-06	0.000381	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CA2—osteoporosis	2.47e-06	0.000373	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—OXCT1—osteoporosis	2.47e-06	0.000373	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ADCY5—osteoporosis	2.46e-06	0.000371	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GPX1—osteoporosis	2.45e-06	0.00037	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MGLL—osteoporosis	2.41e-06	0.000363	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—MYC—osteoporosis	2.36e-06	0.000356	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ENO1—osteoporosis	2.35e-06	0.000354	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PSMA5—osteoporosis	2.31e-06	0.000348	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PSMA2—osteoporosis	2.31e-06	0.000348	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.27e-06	0.000342	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—MTHFR—osteoporosis	2.26e-06	0.000341	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYP19A1—osteoporosis	2.18e-06	0.000328	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ENO1—osteoporosis	2.11e-06	0.000317	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PSMA5—osteoporosis	2.07e-06	0.000313	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PSMA2—osteoporosis	2.07e-06	0.000313	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ENO1—osteoporosis	2.06e-06	0.00031	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—IDH2—osteoporosis	2.05e-06	0.000309	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PSMA2—osteoporosis	2.03e-06	0.000305	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PSMA5—osteoporosis	2.03e-06	0.000305	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.93e-06	0.00029	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP19A1—osteoporosis	1.88e-06	0.000283	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ACP5—osteoporosis	1.87e-06	0.000283	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—POMC—osteoporosis	1.81e-06	0.000273	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ADCY5—osteoporosis	1.78e-06	0.000268	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GPX1—osteoporosis	1.77e-06	0.000267	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—TPI1—osteoporosis	1.74e-06	0.000263	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.68e-06	0.000254	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP19A1—osteoporosis	1.64e-06	0.000248	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—P4HB—osteoporosis	1.64e-06	0.000247	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—MTHFR—osteoporosis	1.64e-06	0.000247	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GAPDH—osteoporosis	1.61e-06	0.000242	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TGFB1—osteoporosis	1.6e-06	0.000242	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—RAP1A—osteoporosis	1.57e-06	0.000236	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MYC—osteoporosis	1.54e-06	0.000232	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TGFB1—osteoporosis	1.53e-06	0.000231	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ADCY5—osteoporosis	1.53e-06	0.000231	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GPX1—osteoporosis	1.53e-06	0.00023	CbGpPWpGaD
Norethindrone—ALB—Metabolism—MTHFR—osteoporosis	1.41e-06	0.000212	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ADCY5—osteoporosis	1.38e-06	0.000207	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GPX1—osteoporosis	1.37e-06	0.000207	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ADCY5—osteoporosis	1.34e-06	0.000202	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GPX1—osteoporosis	1.34e-06	0.000202	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—POMC—osteoporosis	1.31e-06	0.000197	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ENO1—osteoporosis	1.27e-06	0.000191	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—MTHFR—osteoporosis	1.26e-06	0.000191	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PSMA2—osteoporosis	1.25e-06	0.000188	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PSMA5—osteoporosis	1.25e-06	0.000188	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MTHFR—osteoporosis	1.23e-06	0.000186	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL6—osteoporosis	1.16e-06	0.000174	CbGpPWpGaD
Norethindrone—ALB—Metabolism—POMC—osteoporosis	1.13e-06	0.00017	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.01e-06	0.000153	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—POMC—osteoporosis	1.01e-06	0.000152	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—POMC—osteoporosis	9.87e-07	0.000149	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ADCY5—osteoporosis	8.27e-07	0.000125	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GPX1—osteoporosis	8.24e-07	0.000124	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MTHFR—osteoporosis	7.61e-07	0.000115	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—POMC—osteoporosis	6.08e-07	9.17e-05	CbGpPWpGaD
